Foundation attends launch of 'Health and Wealth: The Investors’ Guide to AMR, A Growing Global Health Crisis'

MSCI is hosting a roundtable discussion to mark the launch of 'Health and Wealth: The Investors’ Guide to Antimicrobial Resistance (AMR), A Growing Global Health Crisis' , which explores the economic implications and opportunities of AMR. Co-authored with contributions from the Access to Medicine Foundation as part of the Investor Action on Antimicrobial Resistance (IAAMR), the guide emphasises the pharmaceutical industry's role in combating AMR, the one health perspective, and challenges in low- and middle-income countries (LMICs). It also includes a call to action, recommended best practices, and highlights the IAAMR initiative and its investor statement on AMR. 

At the launch event, Twinelle will participate in a roundtable discussion covering themes pertinent to the guide, including: 

• Key challenges and opportunities for investors in addressing AMR within their portfolios. 

• How investment managers can effectively integrate AMR considerations into their investment strategies and risk management frameworks. 

• The role of cross-industry collaboration in advancing investment action on AMR. 

• Practical steps investors can take to incorporate AMR-related risks and opportunities into their decision-making processes. 

During the discussion, Twinelle will draw from the Foundation’s work in its AMR programme, including key findings and recommendations from the recently published report “How can pharma get the few promising drugs in development to patients battling superbugs?” and the 2021 report “Biotechs are saving the world from superbugs. Can they also save themselves?” Twinelle will also cover best practices from the 2021 AMR Benchmark and the call-to-action section of 'Health and Wealth: The Investors’ Guide to AMR, A Growing Global Health Crisis', which highlights the Foundation as a key resource for investors to engage with to better shape their interactions with investee companies.